# active_site_0122

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **B** — Position 109 (Nucleophile)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MMLPLLAVSAFASLGAAQTYTSCNPTNSLKTWSLSTDFTQGSSDGWTAISGNVTYGSNGAEFTINKRYDAPTLETNFYIFFGEVEVVMRAANGTGIVSSIVMESDDLDEIDWECTGTDTTQIQTNYFGKGNTTTYDRAIWETVSSPQDEFHTYKVVWTAAAITWYIDGTAVRTLEYADAVDGKNYPQTPMVVKLGIWAGGDPSNSEGTIEWAGGETDYDEVPFTMYVKSVNIINYNPAASYNYTDKTGSYTSIVASNSTTGSGIHSSNSVSVFAPSSSTSTFTSSRALIATASTYPASVQTSSSGVVSLSSSSASSSSAAASSTSGSASAVFTGAAVTNLPSFFFTVFFALAIALAF

[Multiple Choices]
A. Position 92 (Proton donor)
B. Position 109 (Nucleophile)
C. Position 975 (Proton acceptor; for dehydratase activity 1)
D. Position 151 (Proton acceptor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact supplied sequence matches the UniProt entry, which annotates position 109 as the nucleophile. This annotation is transferred by similarity from another UniProt protein, so it supports the key but is not direct experimental evidence for this exact protein.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone does not provide a sufficiently unambiguous general rule for assigning the catalytic role to residue 109 rather than the other listed positions; recognizing a family motif would require protein-specific interpretation.


**Missing item-specific fact**

> The catalytic-residue annotation or a sufficiently informative homolog/structure mapping identifying position 109 as the nucleophile.


**Reason**

> The key is supported by a sequence-matched database annotation, but that annotation and its homolog-based evidence were not supplied in the question. Exact catalytic roles and positions cannot be established from generic sequence heuristics alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied reviewer evidence supports B. The annotated proton donor is at position 113, not the offered position 92, and position 975 exceeds the 357-residue sequence.


### Important caveats

- The active-site annotation is based on similarity to UniProtKB:P27051 (ECO:0000250), not shown here as direct experimental evidence for this sequence.
- The historical entry and current entry both match the supplied sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently unambiguous general rule for assigning the catalytic role to residue 109 rather than the other listed positions; recognizing a family motif would require protein-specific interpretation.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The catalytic-residue annotation or a sufficiently informative homolog/structure mapping identifying position 109 as the nucleophile.",
    "reason": "The key is supported by a sequence-matched database annotation, but that annotation and its homolog-based evidence were not supplied in the question. Exact catalytic roles and positions cannot be established from generic sequence heuristics alone."
  },
  "case_id": "active_site_0122",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry, which annotates position 109 as the nucleophile. This annotation is transferred by similarity from another UniProt protein, so it supports the key but is not direct experimental evidence for this exact protein."
  },
  "important_caveats": [
    "The active-site annotation is based on similarity to UniProtKB:P27051 (ECO:0000250), not shown here as direct experimental evidence for this sequence.",
    "The historical entry and current entry both match the supplied sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied reviewer evidence supports B. The annotated proton donor is at position 113, not the offered position 92, and position 975 exceeds the 357-residue sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0122",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry, which annotates position 109 as the nucleophile. This annotation is transferred by similarity from another UniProt protein, so it supports the key but is not direct experimental evidence for this exact protein.",
    "evidence_ids": ["C1", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently unambiguous general rule for assigning the catalytic role to residue 109 rather than the other listed positions; recognizing a family motif would require protein-specific interpretation.",
    "missing_item_specific_fact": "The catalytic-residue annotation or a sufficiently informative homolog/structure mapping identifying position 109 as the nucleophile.",
    "reason": "The key is supported by a sequence-matched database annotation, but that annotation and its homolog-based evidence were not supplied in the question. Exact catalytic roles and positions cannot be established from generic sequence heuristics alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied reviewer evidence supports B. The annotated proton donor is at position 113, not the offered position 92, and position 975 exceeds the 357-residue sequence."
  },
  "important_caveats": [
    "The active-site annotation is based on similarity to UniProtKB:P27051 (ECO:0000250), not shown here as direct experimental evidence for this sequence.",
    "The historical entry and current entry both match the supplied sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry Q4WD22 (Crh-like protein 1, A. fumigatus) annotates position 109 as 'Nucleophile' active site (evidence C5/H3). The residue at position 109 in the supplied sequence is indeed E (glutamic acid), consistent with a nucleophile in glycosidase/transglycosylase catalysis. The protein is annotated as a chitinase (EC 3.2.1.14) and chitin transglycosylase (EC 2.4.-.-). However, the evidence code is ECO:0000250 (inferred by similarity from P27051), meaning this is a computational transfer annotation rather than direct experimental determination on this specific protein. The annotation is nonetheless consistent with the known catalytic mechanism of GH75-family transglycosylases.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C1](#evidence-c1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The protein sequence contains recognizable glycoside hydrolase/transglycosylase domain features (e.g., 'IVMESDDLDE' motif region around positions 100-109). Glycosidases and transglycosylases characteristically employ Glu or Asp as the catalytic nucleophile. Position 109 is E (glutamate) located in a conserved catalytic motif region, making it a strong nucleophile candidate. Option C (position 975) is impossible in a 357-residue protein. Option A (position 92 = N, asparagine) is not a typical proton-donating catalytic residue in glycosidases. Option D (position 151 = H, histidine as proton acceptor) is atypical for glycosidase/transglycosylase active sites, which rely on carboxylate residues. By elimination and general glycosidase biochemistry, B is the most defensible choice.


**Missing item-specific fact**

> The precise mechanistic distinction between E109 as 'nucleophile' versus E113 as 'proton donor' in the GH75/Crh family requires family-specific mechanistic knowledge not derivable from sequence alone. However, since position 113 is not offered as a competing option, this does not impede selecting B from the four choices.


**Reason**

> Options A and C are eliminable by basic checks (wrong residue chemistry; position exceeds protein length). Option D (His as proton acceptor) is inconsistent with glycosidase catalytic chemistry. Option B (Glu as nucleophile) aligns with general glycosidase/transglycosylase mechanism knowledge. A model with general enzyme biochemistry knowledge can meaningfully distinguish B from the distractors without memorizing this specific UniProt entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A (N92 as proton donor) and C (position 975 in a 357-aa protein) are clearly incorrect. Option D (H151 as proton acceptor) is inconsistent with glycosidase catalytic chemistry. Only B is biochemically defensible for a glycosidase/transglycosylase active site among the four choices.


### Important caveats

- The UniProt annotation for position 109 as nucleophile is by similarity (ECO:0000250 from P27051), not direct experimental evidence on Crh1 itself. The 2019 Nature Communications paper (PubMed:30971696) provides functional and disruption phenotype data but the active-site residue roles are transferred.
- The protein is a precursor (signal peptide present); numbering is canonical full-length, which matches the supplied sequence.
- The specific role labels 'nucleophile' vs 'proton donor' for E109 vs E113 are family-specific (GH75) assignments; a model distinguishing these two positions would need mechanistic knowledge of this particular enzyme family. However, since E113 is not a competing option, this does not affect answerability from the given choices.
- The reviewer-only evidence was absent from the evaluated model's input; the model must rely on sequence analysis and general biochemical knowledge.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The protein sequence contains recognizable glycoside hydrolase/transglycosylase domain features (e.g., 'IVMESDDLDE' motif region around positions 100-109). Glycosidases and transglycosylases characteristically employ Glu or Asp as the catalytic nucleophile. Position 109 is E (glutamate) located in a conserved catalytic motif region, making it a strong nucleophile candidate. Option C (position 975) is impossible in a 357-residue protein. Option A (position 92 = N, asparagine) is not a typical proton-donating catalytic residue in glycosidases. Option D (position 151 = H, histidine as proton acceptor) is atypical for glycosidase/transglycosylase active sites, which rely on carboxylate residues. By elimination and general glycosidase biochemistry, B is the most defensible choice.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The precise mechanistic distinction between E109 as 'nucleophile' versus E113 as 'proton donor' in the GH75/Crh family requires family-specific mechanistic knowledge not derivable from sequence alone. However, since position 113 is not offered as a competing option, this does not impede selecting B from the four choices.",
    "reason": "Options A and C are eliminable by basic checks (wrong residue chemistry; position exceeds protein length). Option D (His as proton acceptor) is inconsistent with glycosidase catalytic chemistry. Option B (Glu as nucleophile) aligns with general glycosidase/transglycosylase mechanism knowledge. A model with general enzyme biochemistry knowledge can meaningfully distinguish B from the distractors without memorizing this specific UniProt entry."
  },
  "case_id": "active_site_0122",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C1"
    ],
    "judgment": "supported",
    "reason": "UniProt entry Q4WD22 (Crh-like protein 1, A. fumigatus) annotates position 109 as 'Nucleophile' active site (evidence C5/H3). The residue at position 109 in the supplied sequence is indeed E (glutamic acid), consistent with a nucleophile in glycosidase/transglycosylase catalysis. The protein is annotated as a chitinase (EC 3.2.1.14) and chitin transglycosylase (EC 2.4.-.-). However, the evidence code is ECO:0000250 (inferred by similarity from P27051), meaning this is a computational transfer annotation rather than direct experimental determination on this specific protein. The annotation is nonetheless consistent with the known catalytic mechanism of GH75-family transglycosylases."
  },
  "important_caveats": [
    "The UniProt annotation for position 109 as nucleophile is by similarity (ECO:0000250 from P27051), not direct experimental evidence on Crh1 itself. The 2019 Nature Communications paper (PubMed:30971696) provides functional and disruption phenotype data but the active-site residue roles are transferred.",
    "The protein is a precursor (signal peptide present); numbering is canonical full-length, which matches the supplied sequence.",
    "The specific role labels 'nucleophile' vs 'proton donor' for E109 vs E113 are family-specific (GH75) assignments; a model distinguishing these two positions would need mechanistic knowledge of this particular enzyme family. However, since E113 is not a competing option, this does not affect answerability from the given choices.",
    "The reviewer-only evidence was absent from the evaluated model's input; the model must rely on sequence analysis and general biochemical knowledge."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A (N92 as proton donor) and C (position 975 in a 357-aa protein) are clearly incorrect. Option D (H151 as proton acceptor) is inconsistent with glycosidase catalytic chemistry. Only B is biochemically defensible for a glycosidase/transglycosylase active site among the four choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0122",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry Q4WD22 (Crh-like protein 1, A. fumigatus) annotates position 109 as 'Nucleophile' active site (evidence C5/H3). The residue at position 109 in the supplied sequence is indeed E (glutamic acid), consistent with a nucleophile in glycosidase/transglycosylase catalysis. The protein is annotated as a chitinase (EC 3.2.1.14) and chitin transglycosylase (EC 2.4.-.-). However, the evidence code is ECO:0000250 (inferred by similarity from P27051), meaning this is a computational transfer annotation rather than direct experimental determination on this specific protein. The annotation is nonetheless consistent with the known catalytic mechanism of GH75-family transglycosylases.",
    "evidence_ids": ["C5", "H3", "C4", "C1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The protein sequence contains recognizable glycoside hydrolase/transglycosylase domain features (e.g., 'IVMESDDLDE' motif region around positions 100-109). Glycosidases and transglycosylases characteristically employ Glu or Asp as the catalytic nucleophile. Position 109 is E (glutamate) located in a conserved catalytic motif region, making it a strong nucleophile candidate. Option C (position 975) is impossible in a 357-residue protein. Option A (position 92 = N, asparagine) is not a typical proton-donating catalytic residue in glycosidases. Option D (position 151 = H, histidine as proton acceptor) is atypical for glycosidase/transglycosylase active sites, which rely on carboxylate residues. By elimination and general glycosidase biochemistry, B is the most defensible choice.",
    "missing_item_specific_fact": "The precise mechanistic distinction between E109 as 'nucleophile' versus E113 as 'proton donor' in the GH75/Crh family requires family-specific mechanistic knowledge not derivable from sequence alone. However, since position 113 is not offered as a competing option, this does not impede selecting B from the four choices.",
    "reason": "Options A and C are eliminable by basic checks (wrong residue chemistry; position exceeds protein length). Option D (His as proton acceptor) is inconsistent with glycosidase catalytic chemistry. Option B (Glu as nucleophile) aligns with general glycosidase/transglycosylase mechanism knowledge. A model with general enzyme biochemistry knowledge can meaningfully distinguish B from the distractors without memorizing this specific UniProt entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A (N92 as proton donor) and C (position 975 in a 357-aa protein) are clearly incorrect. Option D (H151 as proton acceptor) is inconsistent with glycosidase catalytic chemistry. Only B is biochemically defensible for a glycosidase/transglycosylase active site among the four choices."
  },
  "important_caveats": [
    "The UniProt annotation for position 109 as nucleophile is by similarity (ECO:0000250 from P27051), not direct experimental evidence on Crh1 itself. The 2019 Nature Communications paper (PubMed:30971696) provides functional and disruption phenotype data but the active-site residue roles are transferred.",
    "The protein is a precursor (signal peptide present); numbering is canonical full-length, which matches the supplied sequence.",
    "The specific role labels 'nucleophile' vs 'proton donor' for E109 vs E113 are family-specific (GH75) assignments; a model distinguishing these two positions would need mechanistic knowledge of this particular enzyme family. However, since E113 is not a competing option, this does not affect answerability from the given choices.",
    "The reviewer-only evidence was absent from the evaluated model's input; the model must rely on sequence analysis and general biochemical knowledge."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `Q4WD22` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 107. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q4WD22.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:21.374081+00:00.  

```json
"Q4WD22"
```

Source SHA-256: `2b5098e0eef6293d750026739a991df11b8ed9fc88d7ba6c46a2dddd8788bf00`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q4WD22.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:21.374081+00:00.  

```json
{"flag":"Precursor","includes":[{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"30971696","source":"PubMed"}],"value":"3.2.1.14"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"30971696","source":"PubMed"}],"value":"Chitinase crh1"}}},{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"30971696","source":"PubMed"}],"value":"2.4.-.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"30971696","source":"PubMed"}],"value":"Chitin transglycosylase crh1"}}}],"recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"30971696","source":"PubMed"}],"value":"Crh-like protein 1"}}}
```

Source SHA-256: `2b5098e0eef6293d750026739a991df11b8ed9fc88d7ba6c46a2dddd8788bf00`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q4WD22.json)  
**Locator:** `/features/5`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:21.374081+00:00.  

```json
{"description":"Nucleophile","evidences":[{"evidenceCode":"ECO:0000250","id":"P27051","source":"UniProtKB"}],"location":{"end":{"modifier":"EXACT","value":109},"start":{"modifier":"EXACT","value":109}},"type":"Active site"}
```

Source SHA-256: `2b5098e0eef6293d750026739a991df11b8ed9fc88d7ba6c46a2dddd8788bf00`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q4WD22?format=txt&versions=107)  
**Locator:** `lines 132-134`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 107 / 1.  
**Retrieved:** 2026-11-01T06:28:34.790448+00:00.  

```text
FT   ACT_SITE        109
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P27051"
```

Source SHA-256: `77033a3b4dcbfe2a0b079eb850f5fe45877250853ab15f376544c19a4d49ea3b`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 122. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
